Related Experiment Videos
[Viral hepatitis. Insurance medicine observations]
1Gerling-Konzern Globale Rückversicherungs-Aktiengesellschaft.
Insights
Hepatitis A-E are major global liver diseases, often asymptomatic. Diagnosis relies on serological markers, crucial for differentiating chronic forms like Hepatitis B, C, and D, which impact mortality.
Area of Science:
- Hepatology
- Virology
- Immunology
Context:
- Hepatitis A-E represent the primary cause of liver disease globally.
- Infectious hepatitis is often asymptomatic and resolves without jaundice.
- Diagnosis and differentiation depend on antigen-antibody serological markers.
Purpose:
- To outline the etiological agents and diagnostic approaches for viral hepatitis.
- To highlight the clinical significance of chronic hepatitis B, C, and D.
Summary:
- Hepatitis A-E, caused by distinct viruses, are the leading global causes of liver disease.
- Many cases are asymptomatic, presenting without jaundice, and have high cure rates.
- Serological markers are key for diagnosing and differentiating hepatitis syndromes.
- Chronic hepatitis B, C, and D are significant for insurance and prognosis.
- Chronic persistent hepatitis has a normal life expectancy, unlike chronic active hepatitis, which can lead to cirrhosis, hepatocellular carcinoma, and increased mortality.
Impact:
- Improved understanding of viral hepatitis diagnosis and prognosis.
- Informed clinical management and insurance assessments for chronic liver disease.
- Highlights the mortality risks associated with chronic active hepatitis B, C, and D.
Abstract:
The major cause of liver diseases world-wide are the infectious hepatitis A-E which are due for different viruses. Most of the cases are clinically asymptomatic and without jaundice with a high rate of cure. The diagnosis and the differentiation of the various clinical syndromes are based mainly on serological markers of the involved antigen-antibody-systems. For insurance purposes the chronic hepatitis B, C and D are of great importance. Where chronic persistent hepatitis has a nearly normal life expectancy, chronic active hepatitis which may develop into cirrhosis and/or hepatocellular carcinoma has an increased mortality.